MedTrace Logo

A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)

NCT03802981 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 338

Last updated 2026-02-18

No results posted yet for this study

Summary

The purpose of this registry study is to actively monitor people with GGOs and collect information about them, so that investigators can learn more about these lesions and about the risk of developing lung cancer in study participants whose GGOs are being monitored in the active surveillance program.

Conditions

  • Multiple Ground Glass Opacities (GGOs)

Sponsors & Collaborators

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • Duke University

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • Université de Montréal

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

Principal Investigators

  • James Huang, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-09
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03802981 on ClinicalTrials.gov